Previous studies have shown that the expression level of COX-2 in tumor cells increased, and specific COX-2 inhibitor could inhibit tumor cell proliferation, induce apoptosis, and enhance the sensitivity of tumor cell to chemotherapy drugs. This evidence concerns the gene PTGS2 and neoplasm.